Article
Effects of IL-32 polymorphisms and IL-32 levels on the susceptibility and severity of coronary artery disease.
Journal of clinical laboratory analysis - 1 Jan 2022
Jin Susu, Liu Xiujing, Wang Yingying, Yu Jian, Jiang Minghua
Abstract excerpt
BACKGROUND: Interleukin-32 (IL-32) has long been proposed as a biomarker for coronary artery disease (CAD). We aimed to evaluate the association between IL-32 levels and coronary stenosis severity, IL-32 polymorphisms rs28372698 and rs4786370, and CAD susceptibility. METHODS: A total of 362 patients with definite or suspected CAD that underwent angiography were recruited (CAD group, n = 175; nonobstructive CAD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
